Novartis Pharmaceuticals and Sandoz Products

A B C D E F G J L M N O P R S T U V X Z

Gemcitabine

Gemcitabin Hexal

Gemcitabine
Locally advanced or metastatic bladder cancer, locally advanced or metastatic adenocarcinoma of the pancreas, First line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
Anticancer
Sandoz

Imatinib

Glivec

Imatinib
Chronic myeloid leukemia (Ph+ CML), Ph+ CML in blast crisis, Lymphoblastic leukemia (Ph+ ALL),MDS/MPD,SM,HES,CEL,CD117,GIST,Kit+ GIST, DFSP Protein-tyrosine kinase inhibitor
Novartis Pharmaceuticals

Metformin Hydrochloride

Galvus Met

Vildagliptin, Metformin Hydrochloride
Type 2 diabetes mellitus (T2DM) Diabetes, DPP-4 inhibitors
Novartis Pharmaceuticals

Galvus Met

Vildagliptin, Metformin Hydrochloride
Type 2 diabetes mellitus (T2DM) Diabetes, DPP-4 inhibitors
Novartis Pharmaceuticals

Vildagliptin

Galvus

Vildagliptin
Type 2 diabetes mellitus (T2DM) Diabetes, DPP-4 inhibitors
Novartis Pharmaceuticals

Galvus Met

Vildagliptin, Metformin Hydrochloride
Type 2 diabetes mellitus (T2DM) Diabetes, DPP-4 inhibitors
Novartis Pharmaceuticals

Galvus Met

Vildagliptin, Metformin Hydrochloride
Type 2 diabetes mellitus (T2DM) Diabetes, DPP-4 inhibitors
Novartis Pharmaceuticals